Results 121 to 130 of about 4,011 (176)
Eosinophilic gastroenteritis: The new imitator
Erkan Çağlar
doaj +1 more source
Eosinophilic gastroenteritis in an elderly men associated with antibiotic use post maxillofacial space infection: a case report. [PDF]
Lin R +5 more
europepmc +1 more source
Long-term prognosis and its associated predictive factors in patients with eosinophilic gastroenteritis. [PDF]
Li KW +10 more
europepmc +1 more source
Circumferential Stenosis of the Second Part of the Duodenum Caused by Eosinophilic Gastroenteritis. [PDF]
Honjo H +9 more
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Bailliere's Best Practice and Research in Clinical Gastroenterology, 2005
Eosinophilic gastroenteritis despite its uncommon occurrence is one of the most important primary eosinophilic gastrointestinal disorders, and most commonly presents with abdominal pain. The terminology is, however, misleading because all levels of the gastrointestinal tract from the esophagus to the rectum may be affected.
Seema Khan
exaly +3 more sources
Eosinophilic gastroenteritis despite its uncommon occurrence is one of the most important primary eosinophilic gastrointestinal disorders, and most commonly presents with abdominal pain. The terminology is, however, misleading because all levels of the gastrointestinal tract from the esophagus to the rectum may be affected.
Seema Khan
exaly +3 more sources
Eosinophilic gastroenteritis: an update
Expert Review of Gastroenterology and Hepatology, 2012Eosinophilic gastroenteritis (EGE) is characterized by dense eosinophilic inflammation of one or several digestive tract sections. The symptoms include abdominal pain, weight loss, vomiting and diarrhea. Biopsy samples taken during endoscopic examination allows the diagnosis of the disease.
Angel Arias
exaly +3 more sources
The management of eosinophilic gastroenteritis
Scandinavian Journal of Gastroenterology, 2015Eosinophilic gastroenteritis (EG) is a rare disorder characterized by eosinophilic infiltration of the gastrointestinal tract. No medication at present is approved by the Food and drug administration of United States for the treatment of EG. The rarity of the disease limits our experience with the different management options.
David Wolf, Rahul Gupta, Sachin Sule
exaly +3 more sources

